Details are given of 214 loci known to be associated with human hereditary disease, which have been mapped on both human and mouse chromosomes.
corresponding human ones, but exceptions include the Dmd/DMD and Hprt/ HPRT mutations which cause little, if any, harm in mice. Possible reasons for phenotypic differences are discussed. In most pathological variants the gene product seems to be absent or greatly reduced in both species. The extensive data on conserved segments between human and mouse chromosomes are used to predict locations in the mouse of over 50 loci of medical interest which are mapped so far only on human chromosomes. In about 80% of these a fairly confident prediction can be made. Some likely homologies between mapped mouse loci and unmapped human ones are also given. Sixty six human and mouse proto-oncogene and growth factor gene homologies are also listed; those of confirmed location are all in known conserved segments. A survey of 18 mapped human disease loci and chromosome regions in which the manifestation or severity of pathological effects is thought to be the result of genomic imprinting shows that most of the homologous regions in the mouse are also associated with imprinting, especially those with homologues on human chromosomes lIp and 15q. Useful methods of accelerating the production of mouse models of human hereditary disease include (1) use of a supermutagen, such as ethylnitrosourea (ENU), (2) targeted mutagenesis involving ES cells, and (3) use of gene transfer techniques, with production of 'knockout mutations'.
(J Med Genet 1994;31: [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] The need to develop good animal models of human hereditary disease has been recognised ever since the subject was first reviewed' 2 but, until recently, progress in this field has been slow. It is clear that the most relevant models are likely to emerge when the comparable. human and animal conditions are known to involve homologous loci. In this respect our genetic knowledge of the laboratory mouse outstrips that for all other non-human mammals. The 829 loci recently assigned to both human and mouse chromosomes3 has now risen to 900, well above comparable figures for other laboratory or farm animals. In a previous publication,4 102 loci were listed which were associated with specific human disease, had mouse homologues, and had been located in both species. The number has now more than doubled (table 1A) . Of particular interest are those which have pathological variants in both the mouse and humans: these are listed in table 2. Many other pathological mutations have been detected and located in the mouse; about half these appear to lie in conserved chromosomal segments. Thus the likely position of their human homologues can be predicted with some confidence. Table IA lists 187 autosomal and 27 sex linked loci associated with pathological effects, which have been located on both human and mouse chromosomes.3 They are ordered in terms of the associated human disease(s), sometimes with two entries for particular loci. For ease of reference, table 1B has a tabulation of the same set in alphabetical order of human gene symbols. 5 The MIM number, location, etc come from McKusick's catalogue6 and other work,7 which also gives details of the disorders. Schinzel et a18 also list human clinical disorders with chromosomal localisations of the genes concerned. Information on corresponding mouse genes is given in several publications,3910 while the latest locus map of the mouse"' has been used to show mouse gene locations as distances in centimorgans from the centromere (figures after the full stop). When there is a double zero after the full stop the gene concerned has not yet been localised on the linkage map. Positions of mouse loci on the G banded map are derived from the Mouse Chromosome Atlas.'2 References given in table 1 are for recently reported disease homologies; for earlier ones please consult Human Gene Mapping 1J1. 3 With reference to polycystic kidney disease5'
Homologous loci
it should be noted that the mouse Pkd-1 locus has not been identified but two flanking DNA markers to the human PKD1 locus were used to show that the region concerned mapped to mouse chromosome 17 Mouse chromosomes Figure 2 Oxford A list of mouse loci, in alphabetical order of gene symbols, was scanned for pathological mutants. Data from the first 50 which had been regionally mapped but had as yet no human homologues (from asebia ab to grey lethal gl) were analysed in relation to any neighbouring loci which had regionally assigned human homologues. It was found that for 26 of the loci (that is, over 50%) the position of a human homologue could be confidently predicted because the mouse locus concerned lay within or very close to a known conserved region.
Even higher rates of prediction were obtained when a series of mapped human disease loci without known mouse homologues was analysed. Table 3 shows that for about 80% of these it was possible to predict regional locations of a mouse homologue with a fair degree of confidence. Only future mapping studies will show whether this confidence is justified. and mouse 8, with no other known members. 86 The oncogene/growth factor group of loci seem to be fairly evenly spread over human and mouse chromosomes, with highest numbers on human 1 (7) and mouse 7 (9). NF2  HSDB3  AGS  ALDH2  AACT  C1NH  ATA  BCNS  BWS  MYH7  CYP27  LFHL1  DGI1  MODYI  DTD  DGCR  COL7A1  EJM1  FA  FRDA  HFE  HD  LGCR  LQT  FBN1  ARSB  MENI  FMD  LGMD1  DM  NPS1  NEMI  NFI  UMPS  PGL  PLI  EDH17B1  PWCR  RSTS  GNS  SMCR  SMA  SCAI  SHFD1  DYTI  TCOF1  TRPS1  TSC1  USHI  VWS  VHL  VWF  WRN  WND  ERCC3  ZWS1   17q21 Table 6 Mapped human disease loci and chromosomal regions possibly involved in genomic imprinting879 "4 with homologous regions in the mouse.34 M,P = maternal or paternal inheritance when human anomaly is expressed. Where evidence for imprinting is described as ' Summing up, the philosophy encapsulated by Bateson's injunction: "Treasure your exceptions!" is now bearing fruit, as more and more of the mouse variants which were kept, bred, studied, and placed on the linkage and then the chromosome map are proving to be homologues of human disease loci. Thus, they can be used as models of human hereditary conditions, as appropriate subjects for gene therapy tests, and as aids to the demarcation of conserved segments and therefore to the localisation of human genes. In this respect human and mouse genetic advances can truly be called symbiotic.
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